+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-03-28Number of Pages: 114

Preimplantation Genetic Diagnosis Market - Asia Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023


Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Asia Preimplantation Genetic Diagnosis (PGD): Market Overview
3.1 Introduction
3.2 Market Dynamics
     3.2.1 Drivers
     3.2.2 Restraints
     3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis
     3.3.1 Bargaining Power of Suppliers
     3.3.2 Bargaining Power of Buyers
     3.3.3 Threat of New Entrants
     3.3.4 Threat of Substitutes
     3.3.5 Competitive Rivalry
3.4 Overview of PGD
     3.4.1 Indications and Conditions for PGD
     3.4.2 Primary Candidates for PGD
     3.4.3 Complications Associated with PGD
     3.4.4 Advantages and Disadvantages
     3.4.5 Techniques used for PGD (e.g. FISH, PCR, CGH, etc.)
     3.4.6 Limitations of Techniques
     3.4.7 Risk of PGD
     3.4.8 Average Cost Analysis
3.5 Regulatory Policies and Legality Framework for PGD: Major Countries of Asia
3.6 Market Attractiveness Analysis: Asia Preimplantation Genetic Diagnosis (PGD) Market, by Geography, 2014
3.7 Heat map analysis for key market players
3.8 Number of PGD centers, By Country

Chapter 4 Asia Preimplantation Genetic Diagnosis (PGD) Market Revenue (USD Million), by Test Type, 2013 – 2023
4.1 Overview
4.2 Aneuploidy Screening 
4.3 Chromosomal Aberrations 
4.4 Gender Selection 
4.5 HLA Typing 
4.6 Single Gene Disorder 
4.7 X-linked diseases 

Chapter 5 Asia Preimplantation Genetic Diagnosis (PGD) Market Revenue (USD Million), by End-user, 2013 – 2023
5.1 Overview
5.2 Fertility Clinics 
5.3 Healthcare Facilities
5.4 Academic Institutes and Research Centers 

Chapter 6 Asia Preimplantation Genetic Diagnosis (PGD) Market Revenue (USD Million), by Geography, 2013 – 2023
6.1 Overview
6.2 South Eastern Asia
     6.2.1 Indonesia
     6.2.2 Malaysia
     6.2.3 Philippines
     6.2.4 Singapore
     6.2.5 Thailand
     6.2.6 Rest of SEA
6.3 Eastern Asia
     6.3.1 China
     6.3.2 Japan
     6.3.3 South Korea
     6.3.4 Rest of Eastern Asia
6.4 Southern Asia
     6.4.1 India
     6.4.2 Sri Lanka
     6.4.3 Rest of Southern Asia
6.5 Central Asia
6.6 Western Asia
     6.6.1 Israel
     6.6.2 Turkey
     6.6.3 Jordan
     6.6.4 Saudi Arabia
6.6.5 United Arab Emirates
     6.6.6 Rest of Western Asia

Chapter 7 Current Trends and Recommendations

Chapter 8 Company Profiles
8.1 Genesis Genetics
     8.1.1 Company Overview
     8.1.2 Financial Overview
     8.1.3 Product Portfolio
     8.1.4 Business Strategies
     8.1.5 Recent Developments
8.2 Genea Ltd.
8.3 Illumina, Inc.
8.4 Laboratory Corporation of America Holdings (LabCorp)
8.5 Natera, Inc
8.6 PerkinElmer, Inc.
8.7 Quest Diagnostics, Inc.
8.8 Repro Genetics
8.9 Reproductive Genetics Innovations
8.10 Others


 
 
Back To Top